SCHEMBL10567452

SCHEMBL10567452

COc1ccc(N=Cc2ccc(O)cc2O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.72
▸ HSD17B10 Q99714 3/20 0.72
▸ MEN1 O00255 3/20 0.72
▸ KMT2A Q03164 3/20 0.72
▸ GAA P10253 2/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ MAOB P27338 5/20 0.64
▸ S100B P04271 1/20 0.62
▸ TSHR P16473 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ KDM4E B2RXH2 3/20 0.56
▸ CA1 P00915 3/20 0.53
▸ CA2 P00918 3/20 0.53
▸ ESR1 P03372 2/20 0.53
▸ ESR2 Q92731 2/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10567450 1.00 MAPT (0.72) MAPTHSD17B10MEN1KMT2AGAA
SCHEMBL994960 0.86 MAOB (0.66) MAPTHSD17B10MEN1KMT2AGAA
SCHEMBL994961 0.86 MAOB (0.66) MAPTHSD17B10MEN1KMT2AGAA
SCHEMBL10719675 0.85 MAOB (0.64) MAPTHSD17B10MEN1KMT2AGAA
SCHEMBL11404194 0.85 MAPT (0.64) MAPTHSD17B10MEN1KMT2AGAA
SCHEMBL11404191 0.85 MAPT (0.64) MAPTHSD17B10MEN1KMT2AGAA
SCHEMBL10564981 0.84 MAPT (1.00) MAPTHSD17B10MEN1KMT2AGAA
SCHEMBL10564983 0.84 MAPT (1.00) MAPTHSD17B10MEN1KMT2AGAA
SCHEMBL13385757 0.82 MAOB (0.62) MAPTHSD17B10MEN1KMT2AGAA
SCHEMBL13385780 0.82 MAOB (0.62) MAPTHSD17B10MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4828568-A N-(2,4-DIHYDROXYBENZYLIDENE)AMINO COMPOUNDS AS PRIMARY COUPLERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1989-05-09 — — US claimed
US-11166891-B2 Bis phenyl hexa trien derivatives, preparation method thereof, and composition for skin whitening containing the same as an active ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2021-11-09 — — US disclosed
US-20200078279-A1 BIS PHENYL HEXA TRIEN DERIVATIVES, PREPARATION METHOD THEREOF, AND COMPOSITION FOR SKIN WHITENING CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KP) 2020-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11166891-B2 Bis phenyl hexa trien derivatives, preparation method thereof, and composition for skin whitening containing the same as an active ingredient TYR, MITF, TPH1 MAPT 603/4885HSD17B10 2708/4885MEN1 4248/4885
US-20200078279-A1 BIS PHENYL HEXA TRIEN DERIVATIVES, PREPARATION METHOD THEREOF, AND COMPOSITION FOR SKIN WHITENING CONTAINING THE SAME AS AN ACTIVE INGREDIENT TYR, MITF, TPH1 MAPT 603/4885HSD17B10 2708/4885MEN1 4248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback